Nov 26, 202428 minS0
<p>Moderna and BioNTech are getting all of the attention with their phase 3 clinical trials for lung cancer and melanoma. But someone else is already further ahead. <br/> <br/>French company Ose Immunotherapeutics has...
About this Podcast:
A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life sciences companies are trying to diagnose and cure.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
17%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for PHASE3.
Signup to Generate a PitchQuestions about PHASE3
What is PHASE3 about?
A weekly podcast exploring medicine 4.0 as we launch into the 21st Century of health. Join us as we highlight the science and investment case for the different diseases and conditions that life sciences companies are trying to diagnose and cure.
What has PHASE3 covered recently?
Recent episodes include "VAXXED: And the winner is... with OneVentures and Ose Immunotherapeutics" (26 November 2024, 28 minutes), "VAXXED: Game on, with BASE and WEHI" (19 November 2024, 26 minutes), and "VAXXED: Boom or bust? With Chris Kallos and Pitt Street Research" (12 November 2024, 19 minutes).
How often does PHASE3 publish?
PHASE3 publishes roughly weekly, with episodes averaging 25 minutes across 16 episodes.
How hard is it to get booked on PHASE3?
Booking probability for PHASE3 is 17%, and the host is rated Selective on guests. PHASE3 requires a Pod Score of 80 or higher. PHASE3's contact route on record: public web form.
Who should pitch PHASE3?
The strongest fits for PHASE3 are Scientific Research & Development and Investing & Wealth Management. PHASE3 has a science audience.
About the host
PHASE3 is a science podcast with 16 episodes published.
Host email not verified for this podcastSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Nov 19, 202426 minS0<p>Cancer vaccines are an area that anyone who is anyone is getting into, but it's a field led largely by academics, not-for–profits, and specialist researchers. So this week we go back to basics - science that is...
Nov 12, 202419 minS0<p>In some ways, cancer vaccines are a history of hype and hope, over success. But that hasn't stopped people from trying. In 2024, biotech CEOs are hoping that this time, it's different. <br/><br/>Research houses are...
Nov 5, 202423 minS0<p>Cancer vaccines are a very niche section of cancer treatments. But two companies in Australia – the only two so far to go public with their work in this arena –are working on an even niche area within this. And one...
Oct 29, 202429 minS0<p>Cancer vaccines started out as prevention. Think Gardasil for cervical and oral cancers caused by HPV, and the hepatitis B vaccine for liver cancer.<br/><br/>But today the science has moved on, to therapy vaccines...
View More
Oct 8, 202434 minS0<p>Drone-deliveries of radioactive medicines and diagnostics to Australia's far-flung towns. Radiopharmaceuticals matched with genetic information to tailor precisely the right dose and isotope to a person's cancer...
Oct 1, 202425 minS0<p>The rule of thumb in biotech is that it costs around $1 billion to bring a new therapy from lab to market. Protecting that investment is the patent system. But what if part of your product is not made by your...
Sep 24, 202430 minS0<p>Can Australia create a mine to lab to bedside production line for radiopharmaceutical medicine? It has the reactor, biotechs and the hospitals to do that last two, and even has a growing pool of expertise to run...
Sep 17, 202426 minS0<p>The question we are dancing around in episode 3 of NUKED is whether locking down isotopes supply chains are really the only way to play the radiopharmaceutical game. <br/><br/>We ask <b>Clarity Pharmaceutical...
Sep 10, 202430 minS0<p>In early 2023, one of the first two really big radiopharmaceutical drugs ran into a problem. Novartis' prostate cancer therapy Pluvicto, released only the year before, was suddenly in short supply, snarling up just...
Sep 3, 202426 minS0<p>The radiopharmaceuticals sector is on a knife point. The scope of what nuclear medicine can do is exploding. But the radioisotopes that biotechs need to make those therapies are in very, very short supply. Major...
Aug 27, 202428 minS0<p>Wearable kidneys. Organs on a chip. Xenotransplantation. The future is here.<br/><br/>But is that the future people in biotech are truly looking to? Because the future that Certa Therapeutics CEO Darren Kelly is...
Aug 20, 202423 minS0<p>We may have led you on a bit in the first two episodes... kidney disease is still a big problem despite the massive shifts forward in treating it. There is a long way to go to bring medical sectors -- and governments...
Aug 13, 202425 minS0<p>We speak to Dimerix CEO Dr Nina Webster about why investors are thrilled with her company, as it nears the midway point for its Phase III clinical trial for the rare disease focal segmental glomerulosclerosis...
Aug 6, 202427 minS0<p>Kidney disease is a silent killer, with only 10% of all people knowing they have it before damage has been done. <br/><br/>But in the last five years there's been a surge of work that's resulted in the FDA approving...
PHASE3
Phase III Trailer
Jul 29, 20241 minS0<p>Life sciences more than anywhere else is the successful mashup of money and tech. <br/><br/>I'm Rachel Williamson and this is Phase III, a weekly podcast diving deep into Australian life sciences. In each of our...
Best industries to pitch PHASE3 for
PitchCentric classifies PHASE3 under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like PHASE3
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ